PT  - JOURNAL ARTICLE
AU  - Vaibhav Srivastava
AU  - Shilangi Gupta
AU  - Arbind Kumar Patel
AU  - Madhvi Joshi
AU  - Manish Kumar
TI  - Comparative analysis of SARS-CoV-2 RNA load in wastewater from three different cities of Gujarat, India
AID  - 10.1101/2021.04.08.21254861
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.08.21254861
4099  - http://medrxiv.org/content/early/2021/04/10/2021.04.08.21254861.short
4100  - http://medrxiv.org/content/early/2021/04/10/2021.04.08.21254861.full
AB  - The scientific community has widely supported wastewater monitoring of SARS-CoV-2 due to the early and prolonged excretion of coronavirus in the faecal matter. In the present study, eighteen influent wastewater samples from different wastewater treatment plants and pumping stations (5 samples from Vadodara city, 4 from Gandhinagar, and nine from Ahmedabad city) were collected and analyzed for the occurrence of SARS-CoV-2 RNA in Gujarat province, India. The results showed the highest SARS-CoV-2 genome concentration in Vadodara (3078 copies/ L), followed by Ahmedabad (2968 copies/ L) and Gandhinagar (354 copies/ L). The comparison of genome concentration more or less corresponded to the number of confirmed and active cases in all three cities. The study confirms the potential of the Surveillance of Wastewater for Early Epidemic Prediction (SWEEP) that can be used at a large scale around the globe for better dealing with the pandemic situation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is funded by UNICEF, Gujarat and UKIERI. We also acknowledge the help received from Dr. Arbind K Patel, Mr. Alok Thakur, and other GBRC staffs who contributed towards sample and data analyses.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Our work does not involve human subjects. Hence no ethical approval is needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is included in the paper.